Treatment of type 2 diabetes with a combination of DPIV inhibitor and metformin or thiazolidinedione

Details for Australian Patent Application No. 2006327974 (hide)

Owner Royalty Pharma Collection Trust

Inventors Rachman, Jonathan

Agent Watermark

Pub. Number AU-B-2006327974

PCT Pub. Number WO2007/072083

Priority 0526291.0 23.12.05 GB

Filing date 22 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 4 October 2012

International Classifications

A61K 31/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/426 - 1,3-Thiazoles

A61K 31/4439

A61P 3/10 Drugs for disorders of the metabolism

Event Publications

17 July 2008 PCT application entered the National Phase

  PCT publication WO2007/072083 Priority application(s): WO2007/072083

9 February 2012 Assignment before Grant

  Prosidion Limited The application has been assigned to Royalty Pharma Collection Trust 2007

4 October 2012 Application Accepted

  Published as AU-B-2006327974

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006327981-Thienopyridine derivatives as modulators of metabotropic glutamate receptors

2006327973-Cyclic antimicrobial peptides